Bernabe Jurado-Gamez

Dr. Bernabe Jurado-Gamez


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
JRJosé Ramón Blanco Ramos
José Ramón Blanco Ramos
MCMaria-Jesus Cobos-Ceballos
Maria-Jesus Cobos-Ceballos
FNFrancisco Navarro-Romero
Francisco Navarro-Romero
ISIsabel Sanjoaquin
Isabel Sanjoaquin
FRFrancisco Arnaiz de Las Revillas
Francisco Arnaiz de Las Revillas
JUJavier Ugedo
Javier Ugedo

26 August 2015 in Thorax
Verified
Journal Article
Open access
PDF file
VIValentina Isetta
Valentina Isetta
Miguel NegrínMiguel Negrín
Miguel Negrín
CMCarmen Monasterio
Carmen Monasterio
JMJuan F Masa
Juan F Masa
NFNuria Feu
Nuria Feu
TNThe Spanish Sleep Network
The Spanish Sleep Network
Background Compliance with continuous positive airway pressure (CPAP) therapy is essential in patients with obstructive sleep apnoea (OSA), but adequate control is not always possible. This is clinically important because CPAP can reverse the morbidity and mortality associated with OSA. Telemedicine, with support provided via a web platform and video conferences, could represent a cost-effective alternative to standard care management. Aim To assess the telemedicine impact on treatment compliance, cost-effectiveness and improvement in quality of life (QoL) when compared with traditional face-to-face follow-up. Methods A randomised controlled trial was performed to compare a telemedicine-based CPAP follow-up strategy with standard face-to-face management. Consecutive OSA patients requiring CPAP treatment, with sufficient internet skills and who agreed to participate, were enrolled. They were followed-up at 1, 3 and 6 months and answered surveys about sleep, CPAP side effects and lifestyle. We compared CPAP compliance, cost-effectiveness and QoL between the beginning and the end of the study. A Bayesian cost-effectiveness analysis with non-informative priors was performed. Results We randomised 139 patients. At 6 months, we found similar levels of CPAP compliance, and improved daytime sleepiness, QoL, side effects and degree of satisfaction in both groups. Despite requiring more visits, the telemedicine group was more cost-effective: costs were lower and differences in effectiveness were not relevant. Conclusions A telemedicine-based strategy for the follow-up of CPAP treatment in patients with OSA was as effective as standard hospital-based care in terms of CPAP compliance and symptom improvement, with comparable side effects and satisfaction rates. The telemedicine-based strategy had lower total costs due to savings on transport and less lost productivity (indirect costs). Trial register number NCT01716676.

3 May 2015 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
MCMónica Calderón-Santiago
Mónica Calderón-Santiago
FPFELICIANO PRIEGO-CAPOTE
FELICIANO PRIEGO-CAPOTE
NTNatacha Turck
Natacha Turck
XRXavier Robin
Xavier Robin
BJBernabe Jurado-Gamez
Bernabe Jurado-Gamez
MCMaría D. Luque de Castro
María D. Luque de Castro

22 July 2010 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
BJBernabe Jurado-Gamez
Bernabe Jurado-Gamez
MFM.C. Fernandez-Marin
M.C. Fernandez-Marin
JGJ.L. Gómez-Chaparro
J.L. Gómez-Chaparro
LML. Muñoz-Cabrera
L. Muñoz-Cabrera
JLJ. Lopez-Barea
J. Lopez-Barea
JLJosé López-Miranda
José López-Miranda
The aim of the present study was to evaluate ischaemic reactive hyperaemia (IRH) in obstructive sleep apnoea (OSA) and its relationship with oxidative stress.We studied 69 consecutive patients referred to our Sleep Unit (Reina Sofia University Hospital, Cordoba, Spain). Patients with chronic diseases or those taking medication were excluded. IRH was assessed before and after polysomnography. Morning IRH and oxidative stress markers were compared between patients with (apnoea–hypopnoea index (AHI) ≥5) and without (AHI <5) OSA. Measurements were repeated in 25 severe OSA patients after continuous positive airway pressure (CPAP) therapy.We included 46 OSA patients (mean±sdAHI 49±32.1) and 23 non-OSA subjects (AHI 3±0.9). The OSA patients showed a significant worsening of morning IRH, and a significant increase in malondialdehyde and 8-hydroxydeoxyguanosine levels. Only the oxygen desaturation index independently explained morning IRH, while malondialdehyde levels showed a weak effect on IRH. In severe OSA patients, IRH improved significantly after CPAP treatment, as did malondialdehyde, 8-hydroxydeoxyguanosine and protein carbonyl levels.In OSA patients, endothelial dysfunction and oxidative stress were observed, and IRH worsened after sleep. The increase in oxidative stress was not associated with IRH, while intermittent hypoxia was strongly associated with IRH. In severe OSA patients, CPAP treatment improved oxidative stress and endothelial function.

1 April 2016 in Journal of Proteomics
Verified
Journal Article
Closed access
IOIgnacio Ortea
Ignacio Ortea
Antonio Rodríguez-ArizaAntonio Rodríguez-Ariza
Antonio Rodríguez-Ariza
ECE. Chicano-Gálvez
E. Chicano-Gálvez
MVM.S. Arenas Vacas
M.S. Arenas Vacas
BJBernabe Jurado-Gamez
Bernabe Jurado-Gamez

1 May 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
BJBernabe Jurado-Gamez
Bernabe Jurado-Gamez
EREdgardo Rodríguez-Carballo
Edgardo Rodríguez-Carballo
RBRamon Bartrons
Ramon Bartrons
JRJosé Luis Rosa
José Luis Rosa
FVFrancesc Ventura
Francesc Ventura
Osteogenesis depends on a coordinated network of signals and transcription factors such as Runx2 and Osterix. Recent evidence indicates that microRNAs (miRNAs) act as important post-transcriptional regulators in a large number of processes, including osteoblast differentiation. In this study, we performed miRNA expression profiling and identified miR-322, a BMP-2-down-regulated miRNA, as a regulator of osteoblast differentiation. We report miR-322 gain- and loss-of-function experiments in C2C12 and MC3T3-E1 cells and primary cultures of murine bone marrow-derived mesenchymal stem cells. We demonstrate that overexpression of miR-322 enhances BMP-2 response, increasing the expression of Osx and other osteogenic genes. Furthermore, we identify Tob2 as a target of miR-322, and we characterize the specific Tob2 3′-UTR sequence bound by miR-322 by reporter assays. We demonstrate that Tob2 is a negative regulator of osteogenesis that binds and mediates degradation of Osx mRNA. Our results demonstrate a new molecular mechanism controlling osteogenesis through the specific miR-322/Tob2 regulation of specific target mRNAs. This regulatory circuit provides a clear example of a complex miRNA-transcription factor network for fine-tuning the osteoblast differentiation program.